Anant, Arjun published the artcileAn analytical review for the estimation of montelukast sodium, Related Products of pyridine-derivatives, the publication is Separation Science plus (2022), 5(5), 120-137, database is CAplus.
A review. Montelukast is a highly potent and selective receptor antagonist of cysteinyl leukotrienes (CysLT1) used in chronic asthma and vasoconstriction reduction and also used in allergies, swelling, hay fever, and shortness of breath. For the measurement of montelukast sodium in biol. and pharmaceutical samples, there are different asynchronous and concurrent anal. methods, such as high-performance thin layer chromatog., UV spectroscopy, capillary electrophoresis, high-performance liquid chromatog., and liquid chromatog.-mass spectrometry, have been developed. The pathogenesis of asthma, mechanism of action, and various anal. methods for the detection of montelukast sodium and its combination of dosage forms and biol. samples have been described in the present review. Ranjan et al. suggested the reverse phase high-performance liquid chromatog. approach for estimating montelukast in rabbit plasma and found the best limit of detection result of 1.0 ng/mL. Ezzeldin et al. developed a liquid chromatog. with tandem mass spectrometry system for the simultaneous detection of combinations of montelukast, gliclazide, and nifedipine. The authors conclude that the studies described in the present manuscript will assist researchers in choosing a simple, rapid, and responsive method for the anal. of montelukast sodium and its combinations.
Separation Science plus published new progress about 21829-25-4. 21829-25-4 belongs to pyridine-derivatives, auxiliary class Membrane Transporter/Ion Channel,Calcium Channel, name is Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C17H18N2O6, Related Products of pyridine-derivatives.
Referemce:
https://en.wikipedia.org/wiki/Pyridine,
Pyridine | C5H5N – PubChem